We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

An Effectiveness-implementation Hybrid Study of Social Prescribing in a Singapore Community Hospital Setting

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04840420
Recruitment Status : Not yet recruiting
First Posted : April 12, 2021
Last Update Posted : April 12, 2021
Sengkang Community Hospital
Outram Community Hospital
Information provided by (Responsible Party):
Bright Vision Hospital

Brief Summary:

This research is an effectiveness-implementation hybrid study with two aims:

1) to determine the utility of a WBC (Well Being Coordinator)-driven Social Prescribing model in the intermediate care setting;

and 2) to assess the patient health outcomes associated with the implementation pilot.

The implementation research questions include:

  1. Practical fit: Does the intervention fit with the daily life activities of study participants? What is the level of safety and burdensomeness of the frequency, intensity and duration of the intervention?
  2. Acceptability: What are the acceptance, retention and follow-up rates as the participants move through the intervention? What are the reasons for retention?
  3. Adoption: How well do the WBC carry out the assessment and intervention as planned?

The key hypotheses include:

  1. Participants in the intervention group will incur a higher improvement in perceived general wellbeing and social support than those participants in the control group.
  2. Participants in the intervention group will incur less healthcare utilisation than those in the control group.
  3. Improvement in the perceived general wellbeing and social support will be moderated by the level of social support of participants.

Condition or disease Intervention/treatment Phase
Social Isolation Other: social prescribing Other: usual care Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 804 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: open label randomised control trial
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: An Effectiveness-implementation Hybrid Study of Social Prescribing in a Singapore Community Hospital Setting
Estimated Study Start Date : April 19, 2021
Estimated Primary Completion Date : September 30, 2022
Estimated Study Completion Date : September 30, 2022

Arm Intervention/treatment
Active Comparator: Intervention


The WBCs conducts approximately daily visits to:

  1. collect demographics and baseline data;
  2. co-develop personalised social prescription plan with the participant based on Social Determinants of Health (SDoH) using SBAR4;
  3. referring and accompanying the participant to attend inpatient activities that suit the participant's interests and preferences; and
  4. informing and seeking the participant's agreement with community assets identified for the participant together with CNS.

About 1-week post-discharge, the WBCs will call to check his/her transition back to community and readiness to start attending community activities or receiving services. For community activities, the WBCs and CNS will visit the participant, accompanying him/her to the activity premise on the first day of the activity session and send the participant home after the session.

Other: social prescribing
as above


Usual Care

Inpatient phase For the control group, the interviewer will conduct approximately 2 visits to collect demographics and baseline data. The duration of each visit will range from 15 to 30 minutes.

Community phase For the control group, no intervention will be administered.

Other: usual care
as above

Primary Outcome Measures :
  1. BIT score [ Time Frame: 2 months post discharge ]
    general wellbeing measured by the Brief Inventory of Thriving (BIT),

  2. mMOS-SS score [ Time Frame: 2 months post discharge ]

    social support will be measured by the modified Medical Outcomes Study

    - Social Support Survey (mMOS-SS)

Secondary Outcome Measures :
  1. healthcare utilisation 12months post enrollment [ Time Frame: 12 months post enrollment ]
    The participants' health utilisation will include the polyclinic visit, emergency department visit, Specialist Outpatient Clinic (SOC) visit, unplanned admission and average length of stay.

  2. MBI [ Time Frame: 1 day to 6 months post enrollment ]
    Modified Barthel Index on discharge

  3. qualitative study [ Time Frame: 1 day to 12 months post enrollment ]
    Qualitative semi-structured interviews to understand the experience of participants (in the intervention group)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   21 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • the study team uses 7 categories of SDOH, namely Housing, Food, Economic Stability, Cognition and Learning, Social Environment, Access to Healthcare, and Digital Technologies. If there are care needs related to at least one category of SDOH, the patients will be deemed eligible for the Social Prescribing intervention. In addition, the patient must have the mental capacity to consent and participant in thesurvey.

Exclusion Criteria:

  • The following group of patients will be excluded from the study:

    1. Patients who will be discharged to Nursing Homes;
    2. Patients who are unable to complete the required survey used in this study due to physical/sensory/cognitive impairment; and/or
    3. Patients who are diagnosed with a life-limiting condition with a prognosis of equal or less than 3 months.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04840420

Layout table for location contacts
Contact: Wong Peng Yong, Andrew, MBBS +6569307048 andrew.wong.p.y@singhealth.com.sg
Contact: Png Shi Hui, Noelle +6569307048

Sponsors and Collaborators
Bright Vision Hospital
Sengkang Community Hospital
Outram Community Hospital
Layout table for investigator information
Principal Investigator: Lee Kheng Hock, MBBS Bright Vision Hospital
Study Director: Low Sher Guan, MBBS Sengkang Community Hospital
Study Director: Low Lian Leng, MBBS Outram Community Hospital
Study Director: Kwan Li Feng, Adeline Sengkang Community Hospital
Study Director: Zhao Dan Sengkang Community Hospital
Study Director: Wong Peng Yong, Andrew, MBBS Bright Vision Hospital
Polley MJ, Fleming J, Anfilogoff T, Carpenter A. Making sense of Social Prescribing. Univ Westminst. Published online August 17, 2017:79.
Helen J. Chatterjee, Paul M. Camic, Bridget Lockyer & Linda J. M. Thomson (2018) Non-clinical community interventions: a systematised review of social prescribing schemes, Arts & Health, 10:2, 97-123, DOI:10.1080/17533015.2017.1334002

Layout table for additonal information
Responsible Party: Bright Vision Hospital
ClinicalTrials.gov Identifier: NCT04840420    
Other Study ID Numbers: 2021/2116
First Posted: April 12, 2021    Key Record Dates
Last Update Posted: April 12, 2021
Last Verified: April 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Bright Vision Hospital:
well-being coordinators
social prescribing